Basal Cell Carcinoma Treatment Size, Share and Forecast (2019-2026)
However, side effects associated with the treatment and long approval time for the drugs may hamper the growth of the market.
(EMAILWIRE.COM, August 30, 2019 ) Market Overview
Basal cell carcinoma (BCC) is a type of skin cancer which begins in the basal cell, a cell within the skin that produces new skin cells as old ones die off.
Basal cell carcinoma occurs mostly in areas of the skin that are exposed to the sun, such as the head and neck.
Growth and Trends
Primary market drivers include increased incidence of basal cell carcinoma globally as it is one of the most common forms of skin cancer.
BCC is more common in white-skinned individuals.
Also, environmental factors leading to more significant exposure to UV radiation also drive market growth.
However, side effects associated with the treatment and long approval time for the drugs may hamper the growth of the market.
Market Size and Segmentation
• The global Basal Cell Carcinoma Treatment market report segments the market by treatment type, by end-user, and by region.
• Based on the treatment type, the market is classified into surgical techniques, drugs, and others.
• Surgical techniques further include excisional surgery,
• non-melanoma skin cancer
• squamous cell carcinoma
• electrodesiccation & cutterage, Moh’s micrographic surgery, and cryosurgery.
• The drugs segment is sub-segmented into topical medications and oral medicines.
• The other segment is sub-segmented into radiation therapy, photodynamic therapy, and laser therapy.
• Surgical treatments for Basal Cell Carcinoma are likely to remain more in demand over the forecast period.
• By end-user, the market is segmented into hospitals, specialty clinics, and others.
View full report: https://www.datamintelligence.com/research-report/basal-cell-carcinoma-treatment-market
Key Players
Pharmaceuticals International, Inc.,
• Sun Pharmaceuticals Ltd.
• F. Hoffmann-La Roche Ltd.
• Mylan N.V.
• Merck & Co., Inc.
• Others
By Treatment Type
• Surgical Techniques
• Drugs
• non-melanoma skin cancer
• squamous cell carcinoma
• Others
By End-User
• Hospitals
• Specialty Clinics
• Cancer Research Institutes
Geographical Share
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Download free sample: https://www.datamintelligence.com/download-sample/basal-cell-carcinoma-treatment-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Basal cell carcinoma (BCC) is a type of skin cancer which begins in the basal cell, a cell within the skin that produces new skin cells as old ones die off.
Basal cell carcinoma occurs mostly in areas of the skin that are exposed to the sun, such as the head and neck.
Growth and Trends
Primary market drivers include increased incidence of basal cell carcinoma globally as it is one of the most common forms of skin cancer.
BCC is more common in white-skinned individuals.
Also, environmental factors leading to more significant exposure to UV radiation also drive market growth.
However, side effects associated with the treatment and long approval time for the drugs may hamper the growth of the market.
Market Size and Segmentation
• The global Basal Cell Carcinoma Treatment market report segments the market by treatment type, by end-user, and by region.
• Based on the treatment type, the market is classified into surgical techniques, drugs, and others.
• Surgical techniques further include excisional surgery,
• non-melanoma skin cancer
• squamous cell carcinoma
• electrodesiccation & cutterage, Moh’s micrographic surgery, and cryosurgery.
• The drugs segment is sub-segmented into topical medications and oral medicines.
• The other segment is sub-segmented into radiation therapy, photodynamic therapy, and laser therapy.
• Surgical treatments for Basal Cell Carcinoma are likely to remain more in demand over the forecast period.
• By end-user, the market is segmented into hospitals, specialty clinics, and others.
View full report: https://www.datamintelligence.com/research-report/basal-cell-carcinoma-treatment-market
Key Players
Pharmaceuticals International, Inc.,
• Sun Pharmaceuticals Ltd.
• F. Hoffmann-La Roche Ltd.
• Mylan N.V.
• Merck & Co., Inc.
• Others
By Treatment Type
• Surgical Techniques
• Drugs
• non-melanoma skin cancer
• squamous cell carcinoma
• Others
By End-User
• Hospitals
• Specialty Clinics
• Cancer Research Institutes
Geographical Share
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Download free sample: https://www.datamintelligence.com/download-sample/basal-cell-carcinoma-treatment-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results